Wikipedia -WSS

Wikipedia

author：explore 2025-09-07 17:23:34 - browse：76

The FDA building -- First Opinion coverage from STAT — Adobe

A panel of expert advisers to the Food and Drug Administration on Friday voted in favor of expanding the use of CAR-T therapy in blood cancer, despite concerns about the powerful treatment’s side effects.

The group voted 11-0 that the benefits of Carvykti, a CAR-T medicine from Johnson & Johnson and Legend Biotech, outweighed its risk for patients with multiple myeloma whose disease has persisted despite initial treatment. The same panel voted 8-3 in favor of Abecma, from Bristol Myers Squibb and 2seventy Bio, for multiple myeloma patients who’ve received at least two lines of therapy. Currently both medicines are approved only for patients who have been treated for myeloma with four or more medications.

In clinical trials, each drug proved to significantly delay disease progression compared to standard therapy. But zooming in on the data, the FDA observed an alarming imbalance of deaths in the early months of both studies, finding that more patients in the CAR-T group died of myeloma or side effects than those receiving the standard of care.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： EQRx, failed developer of low

entertainment

WSS

How to increase colonoscopy rates? Looks like an AI can help

Scientists inch closer to single

At ASCO, AstraZeneca reports strong data for breast cancer drug

ASCO: AstraZeneca says CAR

What the airline industry can learn from medicine

Ionis drug prevents swelling attacks due to hereditary angioedema

knowledge

Wikipedia

entertainment

Drug repurposing or repositioning? The language matters

Infectious disease expert Jeanne Marrazzo assumes Fauci role

Apple is now the first public company to be valued at $3 trillion

At ASCO, AstraZeneca reports strong data for breast cancer drug

Hepatitis C has a cure — but many Americans still lack access to it

Ionis drug prevents swelling attacks due to hereditary angioedema

Novavax promises a turnaround & Lilly roils the obesity market

Kaiser's Risant Health gobbled up Geisinger. Who is next?

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Innovation in antibiotics is ailing. 'Brain drain' may kill it

hotspot

ASCO Daily Recap: Safety data from Novartis, survival from Pfizer

Mega Millions pot grows to $1.25 billion after no winner

Physician groups backed by private equity giant lobby on mergers

Lawsuit alleges UnitedHealth Group unit illegally denied claims

Trump indictment: Who are the 'co

Vertex non

entertainment

focus

entertainment

hotspot